SB 1283, legislation requiring PBMs to obtain a certificate of authority to operate and outlining the role, responsibilities and authority of the Department of Insurance and Financial Institutions, was heard in the House Regulatory Affairs Committee on March 22 where is was amended and voted (6-1) with “Do Pass Amended”.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Gov. Katie Hobbs (D) vetoed SB (Senate Bill) 1248, legislation repealing several components of the sunrise process for scope expansion, including pharmacy.
Also in Arizona, on March 6, SB 1254 (Senate Engrossed), legislation repealing the requirement for a Schedule II opioid prescription that is directly dispensed by a pharmacist and that is not for the immediate administration to the ultimate user to have a red cap, failed to pass the House Health and Human Services Committee by a 3-4 vote.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
SB 1248, legislation repealing several components of the sunrise process for scope expansion, including pharmacy, passed the Senate (21-9) and the House (42-18) and was sent to the Gov. Katie Hobbs (D) for signature. The sunrise process will require material changes to certification, registration, or licensure.
Also in Arizona, on February 20, SB 1254 (Senate Engrossed), legislation repealing the requirement for a Schedule II opioid prescription that is directly dispensed by a pharmacist and that is not for the immediate administration to the ultimate user to have a red cap, passed the Senate and was transmitted to the House.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy Task Force Committee-Rules Writing meeting will be held on February 22 at 9:00 a.m. An agenda has not been posted on the website.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
SB 1460, permitting pharmacists to test and treat for influenza, a respiratory infection and a condition related to a public health threat by the Department of Health Services for which a statewide standing order, rule or executive order is issued, will not advance this year. Stakeholder meetings will take place in the interim in preparation for legislation in 2024.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
NACDS, along with the Arizona Independent Pharmacy Coalition and American Pharmacies, sponsored “Putting Patients Before Profits in Healthcare.” The breakfast briefing for state legislators and staff provided information about how PBMs currently operate in the marketplace and the adverse impacts these practices are having on patients, prescribers, and pharmacies.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Notice of Final Rulemaking related to Pharmacist Delegation/Technicians was published in the “Arizona Administrative Register” with an effective date of July 2, 2022. See PDF pages 994-998.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy informed licensees about a scam involving a letter that is coming from the Board. The SCAM letter indicates suspension of license with opportunity to restore it by obtaining authorization from the concerned department. There is also a follow-up call to the licensee asking to wire money to resolve the issue. As a reminder, this is contrary to Board operations, the Board posted a process to manage complaints. Please reach out to the Arizona Board of Pharmacy using the contact information on the Board’s website directly if you receive suspicious mail, fax, or phone calls.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
HB 2841, the general appropriations act (2022-2023), includes funding for the Organized Retail Theft (ORT) Task Force; see page 9 for details.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.